IL28058A - Preparation of an anti-rh gamma globulin - Google Patents
Preparation of an anti-rh gamma globulinInfo
- Publication number
- IL28058A IL28058A IL28058A IL2805867A IL28058A IL 28058 A IL28058 A IL 28058A IL 28058 A IL28058 A IL 28058A IL 2805867 A IL2805867 A IL 2805867A IL 28058 A IL28058 A IL 28058A
- Authority
- IL
- Israel
- Prior art keywords
- precipitate
- iii
- solution
- preparation
- supernatant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
PATENT ATTORNEYS 1 REINHOLD COHN MICHAEL COHN ISRAEL SHACHTER C PATENTS AND DESIGNS ORDINANCE SPECIFICATION Preparation of an globulin ORTHO corporation of the State of New of Hew do hereby declare the nature of this invention and in what manner the same is to be to be particularly described and ascertained in and by the following statement 163 plasminogen and Supernatant III consists principally o gamma globulins and minor amounts of fibrinogen and The final step of the fractionation yields Precipitate which is essentially pure gamma G globulin almost completely free of 19 S and lipids Precipitate II prepared by the the inventio an gamm The may more fully understood with ence to the following Human blood plasma is cooled to The plasma is centrifuged in a Sharpies with in at feeding at the rate 1000 per The cold insoluble precipitate is The of the natant adjusted to The methanol content of the batc is brought to the addition of 177 methanol per liter of The solution is stirred slow at for one hour and is maintained at The solution is centrifuged in a Sharpies trifuge with in at feeding at the of 1000 100 per Supernatant I is collected in bowl equipped with To each liter of Supernatant I there is with 601 of of 10 acetic and of 4 sodium aceta This brings the methan concentration to the strength to and the pH to The solution is brought to a temperature of and is stirred alowly for two The solution is then allowed to stand for 16 times weight o Preoipitate II III of To the 5 suspension added 2 volumes weight of Precipitate III of sodium A further 1 1 time ieight of Preoipitate II III of water containing of acetate buffer for each gram of Precipitate II III The acetate buffer is prepared by diluting 40 o 10 acid and 20 of 4 sodium acetate to 100 with distilled The pH of the solution is The solution is stirred slowly for one There is then added volumes times the original weight of Precipitate II III of ice water and volumes times the original weight of Precipitate II of methanol while maintaining the temperature at The solution is stirred slowly for one hour and allowed stand The solution contains methanol and has a pH of and an ionic strength The solution is centrifuged in a Sharpies trifuge with a at a temperature of and at a flow rate o 500 50 per The volume 6f Supernatant III is Precipitate III is Supernatant III treated with V 512 and is stirred for 20 The is filtered through an filter press containing An acetate buffer of pH made up as 25 sodium acetate and 3 10 acetic acid made up to 100 with distilled The acetate buffer is diluted 100 times with This solutio has an ionic strength of An Eitel filter press is precoated with the acetate buffer plus Cellte 512 gm of pad using 40 of inch of pad surface Supernatant III is filtered and to the filtrate is added of sodium chloride and of 1 bicarbonate per lite o filtered Supernatant The pH of insufficientOCRQuality
Claims (1)
1. 20 and onic strength being between and 21 gi llter and separating from the resulting liquid system a fourth i 22 precipitate and a fourth 23 adding methanol to said fourth precipitate and 24 adjusting the temperature to about the amount of said methano 25 being between and the pH being between and and the strength being between and and 27 separating from the resulting liquid system a fifth precipitate 28 a fifth 29 adding methanol to said fifth supernatant and 30 adjusting the temperature to about the amount of said methanol being between and the pH being between 32 and and the ionic strength being between and 33 and separating said resulting liquid system into a sixth precipita 34 and a sixth A method according to Claim wherein said sixth precipitate is insufficientOCRQuality
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55517566A | 1966-06-03 | 1966-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL28058A true IL28058A (en) | 1971-08-25 |
Family
ID=24216259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL28058A IL28058A (en) | 1966-06-03 | 1967-05-29 | Preparation of an anti-rh gamma globulin |
Country Status (14)
Country | Link |
---|---|
US (1) | US3449314A (en) |
BE (1) | BE699251A (en) |
CH (1) | CH543886A (en) |
CS (1) | CS154570B2 (en) |
DE (1) | DE1617718A1 (en) |
DK (1) | DK114996B (en) |
ES (1) | ES341266A1 (en) |
FI (1) | FI47374C (en) |
GB (1) | GB1163493A (en) |
GR (1) | GR32294B (en) |
IL (1) | IL28058A (en) |
NL (1) | NL6707646A (en) |
NO (1) | NO122991B (en) |
SE (1) | SE331886C (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3916026A (en) * | 1968-09-19 | 1975-10-28 | Biotest Serum Institut Gmbh | Method for the preparation of gamma-globulin suitable for intravenous use |
DE2624373C2 (en) * | 1976-05-31 | 1983-02-03 | Arnold Dr. 8782 Karlstadt Seufert | Process for the production of sterile filtered cryoprecipitate with an enrichment of factor VIII |
US6096872A (en) * | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
AU784808B2 (en) * | 2001-04-02 | 2006-06-29 | Kedrion Melville Inc. | Prion and viral clearance process |
CN100507567C (en) | 2002-05-23 | 2009-07-01 | 奥索临床诊断有限公司 | Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration |
AU2005229674B2 (en) * | 2004-11-18 | 2010-11-04 | Kedrion Melville Inc. | Low concentration solvent/detergent process of immuneglobulin with pre-treatment |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2390074A (en) * | 1942-02-09 | 1945-12-04 | Research Corp | Protein product and process |
US2770616A (en) * | 1951-01-29 | 1956-11-13 | Protein Foundation Inc | Fractionation of proteinaceous materials in blood plasma and liver tissue |
US2761808A (en) * | 1952-09-06 | 1956-09-04 | Ortho Pharma Corp | Plasma fractionation process |
US2761811A (en) * | 1954-07-22 | 1956-09-04 | Ortho Pharma Corp | Preparation of blood fraction for use in rh testing procedures |
US2761810A (en) * | 1954-07-22 | 1956-09-04 | Ortho Pharma Corp | Preparation of blood fraction for use in rh testing procedures |
US2761809A (en) * | 1954-07-22 | 1956-09-04 | Ortho Pharma Corp | Preparation of blood fraction for use in rh testing procedures |
US2790790A (en) * | 1954-11-10 | 1957-04-30 | Swift & Co | Protein fractionation |
US3361732A (en) * | 1964-07-28 | 1968-01-02 | Dow Chemical Co | Method for concentration of blood protein solutions employing methanol and flash evaporation |
-
1966
- 1966-06-03 US US555175A patent/US3449314A/en not_active Expired - Lifetime
-
1967
- 1967-05-29 IL IL28058A patent/IL28058A/en unknown
- 1967-05-30 DE DE19671617718 patent/DE1617718A1/de active Pending
- 1967-05-30 CH CH763667A patent/CH543886A/en not_active IP Right Cessation
- 1967-05-31 GB GB25107/67A patent/GB1163493A/en not_active Expired
- 1967-05-31 BE BE699251D patent/BE699251A/xx unknown
- 1967-06-01 NL NL6707646A patent/NL6707646A/xx unknown
- 1967-06-01 ES ES341266A patent/ES341266A1/en not_active Expired
- 1967-06-02 DK DK288767AA patent/DK114996B/en unknown
- 1967-06-02 GR GR670132294A patent/GR32294B/en unknown
- 1967-06-02 SE SE774067A patent/SE331886C/en unknown
- 1967-06-02 NO NO168449A patent/NO122991B/no unknown
- 1967-06-02 CS CS404867A patent/CS154570B2/cs unknown
- 1967-06-02 FI FI671561A patent/FI47374C/en active
Also Published As
Publication number | Publication date |
---|---|
ES341266A1 (en) | 1968-06-16 |
CH543886A (en) | 1973-11-15 |
CS154570B2 (en) | 1974-04-30 |
DE1617718A1 (en) | 1971-07-15 |
GB1163493A (en) | 1969-09-04 |
SE331886B (en) | 1971-01-18 |
SE331886C (en) | 1974-01-28 |
FI47374B (en) | 1973-07-31 |
DK114996B (en) | 1969-08-25 |
US3449314A (en) | 1969-06-10 |
NO122991B (en) | 1971-09-13 |
BE699251A (en) | 1967-11-30 |
NL6707646A (en) | 1967-12-04 |
FI47374C (en) | 1973-11-12 |
GR32294B (en) | 1967-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7125552B2 (en) | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates | |
Booyse et al. | In vitro incorporation of amino-acids into the contractile protein of human blood platelets | |
JPH0231687A (en) | Purification of serum albumin | |
US4332717A (en) | Purification of human growth hormone | |
IL28058A (en) | Preparation of an anti-rh gamma globulin | |
IE56981B1 (en) | Purification of interferon | |
US2793203A (en) | Process of preparing stable, highly purified gamma globulin preparations | |
JPH0533239B2 (en) | ||
US4476109A (en) | Method of preparing gamma globulin suitable for intravenous administration | |
US4075197A (en) | Serum albumin production | |
Saunders | Venom of the stonefish Synanceja verrucosa | |
Ito et al. | Purification, crystallization, and properties of bovine milk catalase | |
US3003918A (en) | Production of ceruloplasmin in a purified state from blood plasma fractions | |
Carlström | The heterogeneity of lactoperoxidase | |
US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
US5391713A (en) | Interferon purification process | |
BG96578A (en) | METHOD FOR OBTAINING PURIFIED LYSOZYME DIMERS | |
Taylor et al. | An improved procedure for the preparation of human serum albumin from placental extracts | |
CN110467664A (en) | A method of isolating and purifying serum globulins | |
FUNATSU et al. | Structure and Toxic Function of Ricin I Purification Procedures of Ricin D | |
DE2014957C2 (en) | Process for purifying proteins from blood serum or plasma | |
DE3279292D1 (en) | Blood fractionation improvement | |
Van Regenmortel | Purification of a watermelon mosaic virus | |
Manderino et al. | Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography | |
US2957809A (en) | Insulinase |